questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Composants de génome
Gènes
Exons VDJ
Exons VDJ : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cancer-Associated Fibroblasts
Diagnostic
5
Séquençage de l'ADN
Anomalies génétiques
Imagerie médicale
Analyse moléculaire
Anticorps
Réarrangements génétiques
Tests génétiques
Fiabilité des tests
Symptômes
5
Infections
Troubles immunitaires
Anomalies génétiques
Symptômes
Troubles immunitaires
Symptômes
Symptômes
Troubles immunitaires
Prévention
5
Prévention
Anomalies génétiques
Mode de vie sain
Système immunitaire
Tests génétiques
Prévention
Conseils génétiques
Anomalies génétiques
Traitements
5
Thérapies immunosuppressives
Transfusions
Thérapie génique
Recherche
Médecine personnalisée
Anomalies génétiques
Complications
5
Infections
Troubles auto-immuns
Cancer
Anomalies génétiques
Complications
Gestion des maladies
Surveillance médicale
Complications
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Infections virales
Facteurs de risque
Sexe
Anomalies génétiques
Facteurs environnementaux
Toxines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Exons VDJ : Questions médicales les plus fréquentes",
"headline": "Exons VDJ : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Exons VDJ : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-17",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Exons VDJ"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gènes",
"url": "https://questionsmedicales.fr/mesh/D005796",
"about": {
"@type": "MedicalCondition",
"name": "Gènes",
"code": {
"@type": "MedicalCode",
"code": "D005796",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Exons VDJ",
"alternateName": "VDJ Exons",
"code": {
"@type": "MedicalCode",
"code": "D050441",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Feng Wang",
"url": "https://questionsmedicales.fr/author/Feng%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo 315040, Zhejiang, China."
}
},
{
"@type": "Person",
"name": "Sai Wang",
"url": "https://questionsmedicales.fr/author/Sai%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China."
}
},
{
"@type": "Person",
"name": "Yue Han",
"url": "https://questionsmedicales.fr/author/Yue%20Han",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China."
}
},
{
"@type": "Person",
"name": "Leping Shao",
"url": "https://questionsmedicales.fr/author/Leping%20Shao",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China."
}
},
{
"@type": "Person",
"name": "Mateusz Kaduk",
"url": "https://questionsmedicales.fr/author/Mateusz%20Kaduk",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identification of cancer-associated fibroblasts subtypes in prostate cancer.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/37033924",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1133160"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer.",
"datePublished": "2022-10-16",
"url": "https://questionsmedicales.fr/article/36244987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05320-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37000314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10495-023-01828-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.",
"datePublished": "2022-10-25",
"url": "https://questionsmedicales.fr/article/36284087",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05351-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37170098",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12964-023-01093-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Exons VDJ",
"item": "https://questionsmedicales.fr/mesh/D050441"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Exons VDJ - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Exons VDJ",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Exons VDJ",
"description": "Comment diagnostiquer une anomalie des exons VDJ ?\nQuels tests sont utilisés pour les exons VDJ ?\nLes exons VDJ peuvent-ils être détectés par imagerie ?\nQuels marqueurs indiquent des problèmes avec les exons VDJ ?\nLes tests génétiques sont-ils fiables pour les exons VDJ ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Cancer-Associated+Fibroblasts#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Exons VDJ",
"description": "Quels symptômes sont liés aux anomalies des exons VDJ ?\nLes symptômes varient-ils selon le type d'anomalie VDJ ?\nLes anomalies VDJ causent-elles des douleurs ?\nPeut-on avoir des symptômes sans anomalie VDJ ?\nLes symptômes des anomalies VDJ sont-ils spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Cancer-Associated+Fibroblasts#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Exons VDJ",
"description": "Peut-on prévenir les anomalies des exons VDJ ?\nLes vaccinations aident-elles à prévenir les complications ?\nUn mode de vie sain peut-il réduire les risques ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes conseils génétiques sont-ils utiles pour les familles ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Cancer-Associated+Fibroblasts#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Exons VDJ",
"description": "Quels traitements existent pour les anomalies VDJ ?\nLa thérapie génique est-elle une option pour les anomalies VDJ ?\nLes antibiotiques sont-ils efficaces contre les anomalies VDJ ?\nLes traitements sont-ils personnalisés pour les anomalies VDJ ?\nLes patients ont-ils besoin de suivi après traitement des anomalies VDJ ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Cancer-Associated+Fibroblasts#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Exons VDJ",
"description": "Quelles complications peuvent survenir avec les anomalies VDJ ?\nLes anomalies VDJ augmentent-elles le risque de cancer ?\nLes complications sont-elles réversibles ?\nLes patients doivent-ils surveiller des signes de complications ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Cancer-Associated+Fibroblasts#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Exons VDJ",
"description": "Quels sont les facteurs de risque pour les anomalies VDJ ?\nL'âge influence-t-il le risque d'anomalies VDJ ?\nLes infections virales augmentent-elles le risque ?\nLe sexe joue-t-il un rôle dans les anomalies VDJ ?\nLes facteurs environnementaux influencent-ils les anomalies VDJ ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Cancer-Associated+Fibroblasts#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des exons VDJ ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par séquençage de l'ADN et analyse des réarrangements génétiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les exons VDJ ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et le séquençage sont couramment utilisés pour évaluer les exons VDJ."
}
},
{
"@type": "Question",
"name": "Les exons VDJ peuvent-ils être détectés par imagerie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les exons VDJ nécessitent des analyses moléculaires, pas d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs indiquent des problèmes avec les exons VDJ ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux d'anticorps ou des réarrangements génétiques peuvent indiquer des problèmes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables pour les exons VDJ ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques sont très fiables pour détecter les anomalies des exons VDJ."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des exons VDJ ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies peuvent entraîner des infections fréquentes et des troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'anomalie VDJ ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la nature et la gravité de l'anomalie."
}
},
{
"@type": "Question",
"name": "Les anomalies VDJ causent-elles des douleurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies VDJ ne causent généralement pas de douleurs, mais des infections peuvent en provoquer."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans anomalie VDJ ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres troubles immunitaires peuvent provoquer des symptômes similaires sans anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Les symptômes des anomalies VDJ sont-ils spécifiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas spécifiques et peuvent ressembler à d'autres troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des exons VDJ ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour les anomalies des exons VDJ."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les complications ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Un mode de vie sain peut-il réduire les risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut renforcer le système immunitaire, mais ne prévient pas les anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les risques et permettre une surveillance précoce."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles pour les familles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques d'anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies VDJ ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies immunosuppressives et des transfusions d'anticorps."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour les anomalies VDJ ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard pour ces anomalies."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les anomalies VDJ ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne traitent pas les anomalies VDJ, mais peuvent traiter les infections secondaires."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés pour les anomalies VDJ ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être personnalisés selon le type et la gravité de l'anomalie."
}
},
{
"@type": "Question",
"name": "Les patients ont-ils besoin de suivi après traitement des anomalies VDJ ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller les infections et l'immunité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les anomalies VDJ ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections récurrentes et des troubles auto-immuns."
}
},
{
"@type": "Question",
"name": "Les anomalies VDJ augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies VDJ peuvent augmenter le risque de développer des cancers hématologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils surveiller des signes de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est cruciale pour détecter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies VDJ ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies VDJ ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies VDJ sont plus fréquentes chez les jeunes enfants et les adolescents."
}
},
{
"@type": "Question",
"name": "Les infections virales augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent augmenter le risque d'anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans les anomalies VDJ ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent être plus fréquentes chez un sexe que l'autre."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les anomalies VDJ ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines ou à des radiations peut augmenter le risque d'anomalies."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo 315040, Zhejiang, China.
Publications dans "Exons VDJ" :
3 publications dans cette catégorie
Affiliations :
Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China.
Department of Dermatology, Peking University First Hospital, Beijing, China.
Publications dans "Exons VDJ" :
3 publications dans cette catégorie
Affiliations :
Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China.
Publications dans "Exons VDJ" :
3 publications dans cette catégorie
Affiliations :
Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark.
Villum Center for Bioanalytical Sciences, University of Southern Denmark, 5230 Odense M, Denmark.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark.
Villum Center for Bioanalytical Sciences, University of Southern Denmark, 5230 Odense M, Denmark.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark.
Villum Center for Bioanalytical Sciences, University of Southern Denmark, 5230 Odense M, Denmark.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark.
Villum Center for Bioanalytical Sciences, University of Southern Denmark, 5230 Odense M, Denmark.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Division of Medical Genetics, Department of Molecular Medicine, Sapienza University, San Camillo-Forlanini Hospital, Italy.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Burning Rock Biotech, Guangzhou, Guangdong 510300, P.R. China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou 510632, China.
International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of pharmacy, Jinan University, Guangzhou 510632, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou 510632, China.
International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of pharmacy, Jinan University, Guangzhou 510632, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou 510632, China.
International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of pharmacy, Jinan University, Guangzhou 510632, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
Publications dans "Exons VDJ" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd, MDC 19, Tampa, FL 33612, USA.
Publications dans "Exons VDJ" :
Cancer-associated fibroblasts (CAFs) are one of the most abundant cell types in tumor microenvironment. However, the phenotypic and functional heterogeneities among CAFs have not been sufficiently inv...
We obtained and analyzed the single-cell RNA-sequencing data from 26 hormone-sensitive prostate cancer samples and 8 castration-resistant prostate cancer samples, along with the analysis of bulk-seque...
We identified two major CAFs subtypes with distinct molecular characteristics and biological functions in prostate cancer microenvironment, namely αSMA+ CAV1+ CAFs-C0 and FN1+ FAP+ CAFs-C1. Another si...
In summary, our results identified the presence of heterogeneous CAFs subtypes in prostate cancer microenvironment and the potential of specific CAFs subtype as therapeutic target for castration-resis...
Despite advances in anticancer therapy, the prognosis of gastric cancer (GC) remains unsatisfactory. Research in recent years has shown that the malignant behavior of cancer is not only attributable t...
Dysregulation of autophagy in cancer-associated fibroblasts (CAFs) has been demonstrated to play a role in malignant phenotypes of human tumors. We intended to investigate the function of CAFs autopha...
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a prominent extracellular matrix (ECM) deposition and poor prognosis. High levels of ECM proteins derived from tumour cells reduce the e...
The primary goal of radiotherapy (RT) is to induce cellular damage on malignant cells; however, it is becoming increasingly recognized the important role played by the tumor microenvironment (TME) in ...
Cancer-associated fibroblasts (CAFs) are known to participate in all stages of cancer progression and are increasingly acknowledged to contribute to therapy resistance. Accumulated evidence suggests t...
In this review we present current knowledge on the field of CAFs role in radiotherapy; we discuss the potential tumorigenic functions of radiation-induced senescent fibroblasts and CAFs and we make an...
Papillary thyroid carcinoma (PTC) has a relatively good prognosis, yet there are some invasive PTC cases with worse clinicopathological features and poor outcome. Cancer-associated fibroblasts (CAFs) ...
Primary liver cancer (PLC) includes hepatocellular carcinoma and intrahepatic cholangiocarcinoma and is the sixth most common cancer worldwide with poor prognosis. PLC is characterized by an abundant ...
Cancer-associated fibroblasts (CAFs) are central players in the microenvironment of solid tumors, affecting cancer progression and metastasis. CAFs have diverse phenotypes, origins and functions and c...
The characteristics of a tumor are largely determined by its interaction with the surrounding micro-environment (TME). TME consists of both cellular and non-cellular components. Cancer-associated fibr...
Fibroblasts have been derived from Benign Prostatic Hyperplasia (BPH) and prostate cancer. RNA from these has been used to perform a transcriptome analysis in order to get a comparative profile of nor...
The study has identified 818 differentially expressed mRNAs and 17 lincRNAs between normal and cancer-associated fibroblasts. Also, 15 potential lincRNA-miRNA-mRNA combinations have been identified wh...
This study identified differentially expressed markers between normal and cancer-associated fibroblasts that would help in targeted therapy against CAFs/derived factors, in combination with convention...
The tumor microenvironment is one of the important drivers of tumor development. Cancer-associated fibroblasts (CAFs) are a major component of the tumor stroma and actively participate in tumor develo...